Bank Of America Believes Shares Of Amgen Are Fairly Valued
March 23, 2015 at 09:51 AM EDT
In a report published Monday, Bank of America analyst Ying Huang reiterated a Neutral rating and $179.00 price target on Amgen, Inc. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.